← FDA DRUG APPROVALS

FDA ANDA · ANDA073586

CARBIDOPA AND LEVODOPA

Sponsor: IDT AUSTRALIA LTD

APPLICATION
ANDA073586
TYPE
ANDA
ORIGINAL APPROVAL
1995-06-29
LATEST ACTION
1997-11-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CARBIDOPA AND LEVODOPADiscontinued
CARBIDOPA 10MG, LEVODOPA 100MG · TABLET · ORAL

Approval history

1997-11-06Manufacturing (CMC) · Supplement 5AP
1997-08-11Manufacturing (CMC) · Supplement 4AP
1997-01-08Manufacturing (CMC) · Supplement 2AP
1997-01-08Manufacturing (CMC) · Supplement 3AP
1997-01-08Manufacturing (CMC) · Supplement 1AP
1995-06-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →